Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma - Contacts and Locations

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

This study is currently recruiting participants.
Information provided by Provectus Pharmaceuticals

Please refer to this study by its ClinicalTrials.gov identifier: NCT00521053

Locations


Australia, New South Wales
	Sydney Melanoma Unit	Recruiting
	Sydney, New South Wales, Australia, 2050
	Contact: Margaret Lett +61 (02) 9911 7304 Margaret.Lett@smu.org.au
	Principal Investigator: John F Thompson, MD

Australia, Queensland
	Princess Alexandra Hospital	Recruiting
	Woolloongabba, Queensland, Australia, 4102
	Contact: Janine Thomas +61 (07) 3844 8500 janine1972@hotmail.com
	Principal Investigator: Mark Smithers, MD

Sponsors and Collaborators

Provectus Pharmaceuticals

Investigators


Principal Investigator:	John F Thompson, MD	Sydney Melanoma Unit